KING OF PRUSSIA, PA, Nov. 13 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, has become a
major corporate sponsor of the Alex's Lemonade Stand Foundation and its work
to fight childhood cancer. According to the US National Institutes of Health,
cancer is the second leading cause of childhood death after accidents in the
United States. This corporate sponsorship reflects MDS Pharma Services'
long-standing therapeutic focus on oncology research. It also fits with the
MDS Pharma Services' brand promise of on-time delivery to expedite drug
discovery and development, a promise which aligns with the Foundation's focus
on curing childhood cancer.
Alex's Lemonade Stand Foundation is a unique organization that traces its
roots back to July 2000, when a four-year-old cancer patient sold lemonade in
her front yard to raise money for pediatric cancer research. For the next four
years, despite deteriorating health, Alexandra (Alex) Scott set up a lemonade
stand annually and inspired others to do the same. By the time she passed away
at the age of eight in August 2004, Alex had raised more than $1 million.
The foundation that bears her name continues her vision of "fighting
childhood cancer, one cup at a time." By September of this year, the
Foundation had raised more than $15 million for childhood cancer research. It
provides grants to support basic oncology research, career development for
oncology researchers, and improved availability of new treatments.
"MDS Pharma Services is proud to be the first contract research
organization to become a major corporate sponsor of the Alex's Lemonade Stand
Foundation," said MDS Pharma Services President David Spaight. "Our
sponsorship puts a human face on the work we do to support oncology drug
discovery and development. The possibility of contributing to advances in
treatments for cancer and other diseases inspires our MDS Pharma Services team
This sponsorship will support two Foundation grant programs: The
Pediatric Oncology Program Infrastructure Awards and the Young Investigator
Awards. The first program provides funding to hire support personnel to
expedite enrollment of children with cancer in clinical trials. The second
program provides start-up funds to allow new researchers and physicians to
pursue promising avenues of investigation. To date, the Foundation has funded
more than 42 pediatric cancer research projects at 30 US institutions.
"We know what a difference new advances in cancer research can make; they
gave Alex four extra years of life and inspired her to start raising money to
help other children with difficult-to-treat cancers," said Alex's mother,
Elizabeth Scott, who runs the Alex's Lemonade Stand Foundation with her
husband Jay. "MDS Pharma Services is contributing to such advances through its
sponsorship of the Foundation and the work that its employees do every day.
Together, our organizations are offering hope and the gift of time to children
In addition to supporting two of the Foundation's grant programs, MDS
Pharma Services will encourage employees at its more than three dozen
locations around the world to set up Alex's Lemonade Stands in 2008. Employees
will be encouraged to take part in the Foundation's Fifth Annual Lemonade Days
from June 6 through 8. During these Lemonade Days, an estimated 10,000
volunteers are expected to organize more than 1,000 Alex's Lemonade Stands
coast to coast in the United States. Visit http://www.alexslemonade.org to
learn more about the Alex's Lemonade Stand Foundation.
About MDS Pharma Services
MDS Pharma Services is retooling key parts of its operations to deliver
on-time performance. The business offers a full spectrum of resources to meet
the drug discovery and development needs of the pharmaceutical and
biotechnology industries. With numerous facilities strategically located
around the world, we apply advanced scientific and technological expertise
throughout the drug discovery and development process - from lead
optimization, pre-IND research, early clinical research (bioequivalence,
phases I-IIa) and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more information,
visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ),
a global life sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 6,200 highly skilled people in
28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222,
24 hours a day.
For further information:
For further information: For Investors: Sharon Mathers, (416) 675-6777
ext. 34721, email@example.com; For Media: Charlene McGrady, (610)
239-7900 ext. 231, firstname.lastname@example.org